Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions

Ji,Qiaoying; Huang,Bifei; Wang,Maofeng; Ren,Zhaoxiang; Zhang,Sha; Zhang,Yongjun; Sheng,Lijian; Yu,Yayao; Jiang,Jinwen; Chen,Debao; Ying,Jun; Yu,Jiong; Qiu,Liuyi; Wan,Rugen; Li,Weimin

doi:10.3892/etm.2014.1503

Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions

Authors:
- Qiaoying Ji
- Bifei Huang
- Maofeng Wang
- Zhaoxiang Ren
- Sha Zhang
- Yongjun Zhang
- Lijian Sheng
- Yayao Yu
- Jinwen Jiang
- Debao Chen
- Jun Ying
- Jiong Yu
- Liuyi Qiu
- Rugen Wan
- Weimin Li
View Affiliations

Affiliations: Department of Respiratory, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang 322100, P.R. China, Pathology Center, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang 322100, P.R. China, Department of Clinical Laboratory Medicine, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang 322100, P.R. China, School of Laboratory Medicine, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R. China, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China, Department of Internal Medicine, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang 322100, P.R. China
Published online on: January 27, 2014 https://doi.org/10.3892/etm.2014.1503
Pages: 778-784

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Clinical history and physical examination are helpful in indicating the potential causes of pleural effusions (PEs). However, the accurate diagnosis and establishment of the causes of PE is an ongoing challenge in daily clinical practice. The primary aim of this study was to distinguish between infectious PE and malignant PE (MPE) by measuring two major acute phase response biomarkers: prealbumin (PA) and C-reactive protein (CRP). The study was a prospective trial involving 151 patients who were diagnosed with infectious PE or MPE. Patients with infectious PE were divided into two subgroups: tuberculous PE (TBPE) and parapneumonic PE (PNPE). A further 58 patients with PEs that showed no evidence of MPE, TBPE or PNPE were classified as the chronic non-specific PE (NSPE) group. Demographic characteristics and pleural fluids of the subjects were collected consecutively. The discriminative properties of pleural fluid routine biochemistries, and PA and CRP were evaluated. PA, CRP and classical fluid parameters were also applied to classify patients with infectious PE and MPE. Receiver operating characteristics (ROC) analysis established the cutoffs of PA and CRP for discriminating between groups. Pleural fluid PA levels were significantly higher in the MPE group (n=47) than in the infectious PE group (n=104). Pleural fluid CRP levels were significantly higher in the infectious PE group than in the MPE group. Pleural fluid PA levels were identified to be moderately negatively correlated with CRP levels in the MPE group, with a statistically significant correlation coefficient of -0.352. The ROC curve showed that the sensitivity and specificity of PA for the diagnosis of MPE were 0.851 and 0.548, respectively, at the cutoff of 28.3 mg/l. The area under the curve (AUC) was 0.784 (95% CI, 0.707‑0.861). Using CRP as a diagnostic parameter resulted in an comparable AUC of 0.810 (95% CI, 0.736-0.885), at the cutoff of 35.2 mg/l. Combinations of PA and CRP resulted in incrementally discriminating values for MPE, with a sensitivity of 0.617 and a specificity of 0.903. The measurement of PA and CRP levels in pleural fluid may be a useful adjunctive test in PE, as a potential differentiator between infectious PE and MPE.

View Figures

View References

1	Light RW: Pleural effusions. Med Clin North Am. 95:1055–1070. 2011. View Article : Google Scholar
2	Stathopoulos GT and Kalomenidis I: Malignant pleural effusion: tumor-host interactions unleashed. Am J Respir Crit Care Med. 186:487–492. 2012. View Article : Google Scholar : PubMed/NCBI
3	Muzumdar H: Pleural effusion. Pediatr Rev. 33:45–47. 2012. View Article : Google Scholar
4	Bays AM and Pierson DJ: Tuberculous pleural effusion. Respir Care. 57:1682–1684. 2012. View Article : Google Scholar : PubMed/NCBI
5	McGrath EE and Anderson PB: Diagnosis of pleural effusion: a systematic approach. Am J Crit Care. 20:119–128. 2011. View Article : Google Scholar : PubMed/NCBI
6	Sutherland JS, Garba D, Fombah AE, et al: Highly accurate diagnosis of pleural tuberculosis by immunological analysis of the pleural effusion. PLoS One. 7:e303242012. View Article : Google Scholar : PubMed/NCBI
7	Ye ZJ, Yuan ML, Zhou Q, et al: Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection. PLoS One. 7:e317102012. View Article : Google Scholar : PubMed/NCBI
8	Meveychuck A, Osadchy A, Chen B and Shitrit D: Pleural effusion in chronic obstructive pulmonary medicine (COPD) patients in a medical intensive care unit: characteristics and clinical implications. Harefuah. 151:198–201. 2552012.(In Hebrew).
9	Froudarakis ME: Pleural effusion in lung cancer: more questions than answers. Respiration. 83:367–376. 2012. View Article : Google Scholar : PubMed/NCBI
10	Wang T, Lv M, Shen S, et al: Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer. PLoS One. 7:e432682012. View Article : Google Scholar : PubMed/NCBI
11	Morgensztern D, Waqar S, Subramanian J, Trinkaus K and Govindan R: Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer. J Thorac Oncol. 7:1485–1489. 2012. View Article : Google Scholar : PubMed/NCBI
12	Cha SI, Shin KM, Jeon KN, et al: Clinical relevance and characteristics of pleural effusion in patients with Mycoplasma pneumoniae pneumonia. Scand J Infect Dis. 44:793–797. 2012. View Article : Google Scholar : PubMed/NCBI
13	Fernández de Larrea C, Duplat A, Giampietro F, et al: Diagnostic accuracy of immunological methods in patients with tuberculous pleural effusion from Venezuela. Invest Clin. 52:23–34. 2011.PubMed/NCBI
14	Botana-Rial M, Casado-Rey P, Leiro-Fernández V, Andrade-Olivié M, Represas-Represas C and Fernández-Villar A: Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion. Clin Lab. 57:373–378. 2011.PubMed/NCBI
15	Porcel JM, Bielsa S, Esquerda A, Ruiz-González A and Falguera M: Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions. Eur J Intern Med. 23:447–450. 2012. View Article : Google Scholar : PubMed/NCBI
16	Porcel JM: Pearls and myths in pleural fluid analysis. Respirology. 16:44–52. 2011. View Article : Google Scholar : PubMed/NCBI
17	Wang Y, Chen Z, Chen J, et al: The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer. Clin Chim Acta. 421:230–235. 2013. View Article : Google Scholar : PubMed/NCBI
18	Wang Z, Wang C, Huang X, Shen Y, Shen J and Ying K: Differential proteome profiling of pleural effusions from lung cancer and benign inflammatory disease patients. Biochim Biophys Acta. 1824:692–700. 2012. View Article : Google Scholar : PubMed/NCBI
19	Park DS, Kim D, Hwang KE, et al: Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions. Yonsei Med J. 54:396–402. 2013. View Article : Google Scholar : PubMed/NCBI
20	Heffner JE: Diagnosis and management of malignant pleural effusions. Respirology. 13:5–20. 2008.
21	Hyun TS, Barnes M and Tabatabai ZL: The diagnostic utility of D2–40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology. Acta Cytol. 56:527–532. 2012.
22	Bass LC, Dillard TA, Forseen CJ and Davis WB: An unusual cause of massive pleural effusion. Am J Med Sci. 344:505–507. 2012. View Article : Google Scholar : PubMed/NCBI
23	Toworakul C, Kasitanon N, Sukitawut W, Wichinun R and Louthrenoo W: Usefulness of pleural effusion antinuclear antibodies in the diagnosis of lupus pleuritis. Lupus. 20:1042–1046. 2011. View Article : Google Scholar : PubMed/NCBI
24	Elsammak MY, Attia A, Hassan HA, Zaytoun TM, Shorman M and Suleman M: Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusion. Tumour Biol. 33:1701–1707. 2012. View Article : Google Scholar : PubMed/NCBI
25	Li J, Li ZN, Bao QL, Ge LP, Li XQ and Chen P: Evaluation of pleural fluid survivin and XIAP for the diagnosis of malignant pleural effusion. Tumour Biol. 33:1803–1810. 2012. View Article : Google Scholar : PubMed/NCBI
26	Trapé J, Molina R, Sant F, et al: Diagnostic accuracy of tumour markers in serous effusions: a validation study. Tumour Biol. 33:1661–1668. 2012.PubMed/NCBI
27	Davidsen JR, Laursen CB and Madsen PH: Measuring pH in pleural fluid is valuable when identifying the cause of purulent pleural effusion. Ugeskr Laeger. 174:1469–1470. 2012.(In Danish).
28	Porcel JM: Pleural fluid biomarkers: beyond the Light criteria. Clin Chest Med. 34:27–37. 2013. View Article : Google Scholar : PubMed/NCBI
29	Lin MY, Liu WY, Tolan AM, Aboulian A, Petrie BA and Stabile BE: Preoperative serum albumin but not prealbumin is an excellent predictor of postoperative complications and mortality in patients with gastrointestinal cancer. Am Surg. 77:1286–1289. 2011.PubMed/NCBI
30	Kawai H: Low perioperative prealbumin level predicts early recurrence after curative pulmonary resection for non-small cell lung cancer. World J Surg. 37:20062013. View Article : Google Scholar
31	Guerra LT, Rosa AR, Romani RF, Gurski RR, Schirmer CC and Kruel CD: Serum transferrin and serum prealbumin as markers of response to nutritional support in patients with esophageal cancer. Nutr Hosp. 24:241–242. 2009.PubMed/NCBI
32	Pinilla JC, Hayes P, Laverty W, Arnold C and Laxdal V: The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. Surgery. 124:799–806. 1998. View Article : Google Scholar : PubMed/NCBI